Table 3.
Estimated 3-year between-group mean difference in change in physical performances from baseline (95% CI).
| ω3-PUFA vs. Placebo | Raw p Value | Adjusted p Value * | ω3-PUFA + Multidomain Intervention vs. Placebo | Raw p Value | Adjusted p Value * | Multidomain Intervention + Placebo vs. Placebo | Raw p Value | Adjusted p Value * | |
|---|---|---|---|---|---|---|---|---|---|
| Repeated chair stand test (s, mean, 95% CI) | −0.053 (−0.680 to 0.572) | 0.866 | 0.866 | −0.393 (−1.021 to 0.234) | 0.219 | 0.438 | −0.601 (−1.225 to 0.022) | 0.058 | 0.176 |
| Handgrip strength (kg, mean, 95% CI) | 0.382 (−0.575 to 1.341) | 0.433 | 0.914 | −0.05253 (−1.006 to 0.901) | 0.914 | 0.914 | −0.108 (−1.060 to 0.843) | 0.823 | 0.914 |
| 4-m walking speed (m/s−1, mean, 95% CI) | −0.015 (−0.053 to 0.023) | 0.435 | 0.737 | −0.00658 (−0.045 to 0.031 | 0.737 | 0.737 | 0.011 (−0.026 to 0.049) | 0.555 | 0.737 |
| SPPB mean, 95% CI) | −0.110 (−0.370 to 0.149) | 0.403 | 0.646 | −0.06058 (−0.319 to 0.198) | 0.646 | 0.646 | 0.067 (−0.191 to 0.325) | 0.609 | 0.646 |
SPPB, Short Physical Performance Battery; * Adjusted for multiple comparisons with the Hochberg procedure to account for the fact that three intervention groups were compared with the placebo group in each analysis; SD, Standard Deviation.